Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Pfizer Inc Company Profile

« Back to Dashboard

Summary for Applicant: Pfizer Inc

Drug Master File Entries: (click here to view)149
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc
methylphenidate hydrochloride
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL207960-002Dec 4, 2015RXNo8,999,386<disabled>Y <disabled>
Pfizer Inc
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-005Apr 4, 2002RXNo<disabled><disabled>
Pfizer Inc
irinotecan hydrochloride
INJECTABLE;INJECTION020571-002Jun 14, 1996RXYes6,403,569*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?